Feline oral cancer, DCM therapies to be exploredJanuary 5, 2021Dilated cardiomyopathy (DCM), oral squamous cell carcinoma (OSCC), and canine distemper virus (CDV) may soon see new treatments, thanks to Morris Animal Foundation.
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
Blood test streamlines canine cancer detectionDecember 9, 2020Texas A&M has introduced a simplified oncology test that allows for early diagnosis in dogs.
MCT intratumoral injectable gets green lightNovember 19, 2020Dogs afflicted with non-metastatic mast cell tumors (MCTs) can now benefit from a new and novel treatment method.
Individualized care central to trial canine osteosarcoma treatment methodNovember 16, 2020Dogs diagnosed with a deadly form of bone cancer may soon have a greater chance of survival, thanks to the expansion of a clinical trial.
$10M financing helps marry canine and human cancer techniquesNovember 6, 2020One Health Company has received sizable funding to help advance precision medicine in canine oncology.
#CurePetCancer aims to defeat deadly diseaseNovember 5, 2020Cancer is among the top killers of America’s dogs and cats, and a new initiative is doing its part to change that.
Cancer research gets $825K boostOctober 16, 2020America’s top veterinarian oncology universities have received additional funding to help in the fight against pet cancer.
Technicians are tops: The changing role of this critical team memberOctober 12, 2020It’s National Veterinary Technician Week, a time when we honor these tireless professionals who have never been more critical to animal health than over the last eight months or so.
Vaccine appears to control canine osteosarcomaJune 25, 2020A research team at the University of Missouri (MU) College of Veterinary Medicine is exploring the use of a patient-specific, precision medicine treatment for bone cancer in dogs,
VPN Plus+ ExclusiveIs immunotherapy the key to wiping out canine cancer?June 24, 2020An intact and functional immune system is essential to protect an organism against invading pathogens and infectious disease. However, the immune system also plays a pivotal role in identifying and eliminating transformed cells that, if left unchecked, would progress to cancer. Clinical evidence of the immune system's ability to control cancer comes from a number of observations in both the veterinary and medical settings. Consider the following examples: Cats receiving chronic immunosuppression following renal transplant have a higher incidence of lymphoma compared with the general feline population1,2 Spontaneous regression of transmissible venereal tumor is associated with an increased proportion of tumor-infiltrating cytotoxic CD8+ T cells3 Canine osteosarcoma patients that develop bacterial infections after limb-sparing surgery experience significantly prolonged survival times.4 The presence of tumor-specific, cytotoxic T cells within tumors, such as ovarian carcinoma, confers a favorable prognosis,5 whereas infiltration with regulatory or suppressor T cells confers a worse prognosis6 These observations, coupled with two decades of experimentation in murine cancer models, indicate that finding ways to initiate, augment, and broaden a patient's antitumor immune response holds promise for the treatment and possible prevention of cancer. Indeed, this is the aim of cancer immunotherapy, and recent advances in this field have …
